Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
Ozempic, Wegovy on list for Medicare drug price negotiations
Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, as well as some blockbuster cancer medications and other drugs,
Medicare announces 15 new drugs up for price negotiations, including Ozempic
The Biden administration on Friday released the next round of prescription drugs selected for Medicare price negotiations, including Ozempic — the blockbuster diabetes drug that’s also used for weight loss. The drug has faced public backlash over its high price, fueling demand for cheaper alternatives.
Medicare announces plan to negotiate prices of diabetes, weight loss drugs
WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy, further complicating big decisions the Trump administration will have to make about how to cover the medications.
Ozempic, Ibrance among next drugs picked by Medicare for price talks
Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health policy acts.
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Ozempic, Trulicity among Medicare's priciest drugs, report finds
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would not discuss Medicare's next round of negotiations because the list of selected drugs is not yet public.
Biden Administration Announces 15 More Drugs For Price Talks
US President Joe Biden's administration on Friday announced a new list of 15 drugs for which it will negotiate lower prices with pharmaceutical companies.
Biden administration picks 15 more drugs for Medicare negotiation
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration officials did not share which drugs had been selected,
Medicare targets 15 more drugs for price negotiations
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
AARP2d
8 Types of Medications That Can Increase Your Risk of Falling
But many people who take daily medications are unaware that certain drugs in their pill box can also increase their risk of ...
Drugmakers hiked prices for hundreds of drugs in early January
January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...